ClinicalTrials.gov record
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
ClinicalTrials.gov ID: NCT01783548
Public ClinicalTrials.gov record NCT01783548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Study identification
- NCT ID
- NCT01783548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 547 participants
Conditions and interventions
Conditions
Interventions
- BDP Nasal Aerosol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2012
- Primary completion
- Sep 30, 2013
- Completion
- Sep 30, 2013
- Last update posted
- Oct 11, 2015
2013
United States locations
- U.S. sites
- 63
- U.S. states
- 23
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10522 | Hot Springs | Arkansas | — | — |
| Teva Investigational Site 10518 | Costa Mesa | California | — | — |
| Teva Investigational Site 10526 | Downey | California | — | — |
| Teva Investigational Site 10496 | Huntington Beach | California | — | — |
| Teva Investigational Site 10536 | Huntington Beach | California | — | — |
| Teva Investigational Site 10479 | Mission Viejo | California | — | — |
| Teva Investigational Site 10524 | Orange | California | — | — |
| Teva Investigational Site 10508 | Paramount | California | — | — |
| Teva Investigational Site 10495 | San Diego | California | — | — |
| Teva Investigational Site 10504 | San Diego | California | — | — |
| Teva Investigational Site 10505 | Stockton | California | — | — |
| Teva Investigational Site 10514 | Centennial | Colorado | — | — |
| Teva Investigational Site 10503 | Colorado Springs | Colorado | — | — |
| Teva Investigational Site 10499 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 10474 | Savannah | Georgia | — | — |
| Teva Investigational Site 10490 | Stockbridge | Georgia | — | — |
| Teva Investigational Site 10498 | Stockbridge | Georgia | — | — |
| Teva Investigational Site 10509 | DeKalb | Illinois | — | — |
| Teva Investigational Site 10493 | Normal | Illinois | — | — |
| Teva Investigational Site 10486 | Indianapolis | Indiana | — | — |
| Teva Investigational Site 10494 | Louisville | Kentucky | — | — |
| Teva Investigational Site 10515 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 10540 | Traverse City | Michigan | — | — |
| Teva Investigational Site 10513 | Columbia | Missouri | — | — |
| Teva Investigational Site 10532 | Missoula | Montana | — | — |
| Teva Investigational Site 10507 | Brick | New Jersey | — | — |
| Teva Investigational Site 10534 | Corning | New York | — | — |
| Teva Investigational Site 10492 | Cortland | New York | — | — |
| Teva Investigational Site 10517 | Niagara Falls | New York | — | — |
| Teva Investigational Site 10482 | Rochester | New York | — | — |
| Teva Investigational Site 10535 | Watertown | New York | — | — |
| Teva Investigational Site 10478 | High Point | North Carolina | — | — |
| Teva Investigational Site 10516 | Holly Springs | North Carolina | — | — |
| Teva Investigational Site 10485 | Canton | Ohio | — | — |
| Teva Investigational Site 10480 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10500 | Cleveland | Ohio | — | — |
| Teva Investigational Site 10529 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 10537 | Ashland | Oregon | — | — |
| Teva Investigational Site 10527 | Medford | Oregon | — | — |
| Teva Investigational Site 10502 | Portland | Oregon | — | — |
| Teva Investigational Site 10477 | Blue Bell | Pennsylvania | — | — |
| Teva Investigational Site 10484 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 10511 | Warwick | Rhode Island | — | — |
| Teva Investigational Site 10497 | Charleston | South Carolina | — | — |
| Teva Investigational Site 10521 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 10528 | Knoxville | Tennessee | — | — |
| Teva Investigational Site 10483 | Boerne | Texas | — | — |
| Teva Investigational Site 10489 | Dallas | Texas | — | — |
| Teva Investigational Site 10520 | Dallas | Texas | — | — |
| Teva Investigational Site 10476 | El Paso | Texas | — | — |
| Teva Investigational Site 10491 | Kerrville | Texas | — | — |
| Teva Investigational Site 10487 | Plano | Texas | — | — |
| Teva Investigational Site 10501 | Plano | Texas | — | — |
| Teva Investigational Site 10523 | San Antonio | Texas | — | — |
| Teva Investigational Site 10531 | San Antonio | Texas | — | — |
| Teva Investigational Site 10539 | San Antonio | Texas | — | — |
| Teva Investigational Site 10475 | Waco | Texas | — | — |
| Teva Investigational Site 10488 | Salt Lake City | Utah | — | — |
| Teva Investigational Site 10506 | Salt Lake City | Utah | — | — |
| Teva Investigational Site 10510 | Salt Lake City | Utah | — | — |
| Teva Investigational Site 10519 | Burke | Virginia | — | — |
| Teva Investigational Site 10481 | Richmond | Virginia | — | — |
| Teva Investigational Site 10533 | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01783548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01783548 live on ClinicalTrials.gov.